Skip to main content
. 2003 Jun;41(6):2391–2394. doi: 10.1128/JCM.41.6.2391-2394.2003

TABLE 4.

Comparative yields of clinically important episodes of infection detected in BM and BD blood culture bottles

Microorganism(s) No. of episodes detected in:
P value
Both bottles BM bottles only BD bottles only
Staphylococcus aureus 75 10 4 NSa
Coagulase-negative staphylococci 28 4 2 NS
Streptococcus spp.b 7 1 1 NS
Enterococcus spp.c 31 4 10 NS
Enterobacteriaceaed 39 5 4 NS
Other gram-negative bacteriae 19 4 4 NS
Yeastsf 19 13 3 <0.025
All microorganisms 220g 41 30h NS
a

NS, not significant (P > 0.05).

b

Includes three viridans group streptococcus, three Streptococcus pneumoniae, and two Streptococcus bovis isolates and one group G streptococcus isolate.

c

Includes 30 Enterococcus faecalis and 14 Enterococcus faecium isolates and 1 Enterococcus avium isolate.

d

Includes 19 Klebsiella pneumoniae, 16 Escherichia coli, 4 Enterobacter cloacae, 2 Proteus mirabilis, and 2 Serratia marcescens isolates and 1 isolate each of Cedecea sp., Citrobacter freundii, Enterobacter aerogenes, Klebsiella oxytoca, and Salmonella enterica serovar Typhi.

e

Includes 11 Pseudomonas aeruginosa, 8 Acinetobacter baumannii, 4 Stenotrophomonas maltophilia, and 2 Burkholderia cepacia isolates and 1 isolate each of Acinetobacter lwoffii and Alcaligenes spp.

f

Includes 20 Candida albicans, 10 Candida glabrata, and 3 Candida tropicalis isolates and 1 isolate each of Cryptococcus neoformans and Hansenula anomala.

g

Includes one isolate each of Aerococcus viridans and Corynebacterium sp.

h

Includes one isolate each of Clostridium perfringens and Bacteroides thetaiotaomicron.

HHS Vulnerability Disclosure